209472-50-4

Upstream product

• 204513-78-0 (S)-2-Benzyloxycarbonylamino-3-[4-(2-cyclohexyl-ethoxy)-3-iodo-phenyl]-propionic acid methyl ester 
• 204513-81-5 (S)-2-Benzyloxycarbonylamino-3-[3-(4-tert-butoxycarbonylamino-butyl)-4-(2-cyclohexyl-ethoxy)-phenyl]-propionic acid methyl ester 
• 204513-79-1 (S)-2-Benzyloxycarbonylamino-3-[4-(2-cyclohexyl-ethoxy)-3-(4-hydroxy-but-1-ynyl)-phenyl]-propionic acid methyl ester 
• 204513-93-9 (S)-2-Benzyloxycarbonylamino-3-[4-(2-cyclohexyl-ethoxy)-3-(4-iodo-butyl)-phenyl]-propionic acid methyl ester 
• 204513-80-4 (S)-2-Benzyloxycarbonylamino-3-[4-(2-cyclohexyl-ethoxy)-3-(4-hydroxy-butyl)-phenyl]-propionic acid methyl ester 
• 79677-58-0 2-amino-3-(3-iodo-4-hydroxyphenyl)propionic acid methyl ester hydrochloride 
• 79677-60-4 (S)-N-benzyloxycarbonyl-3-(4-hydroxy-3-iodophenyl)alanine methyl ester 
• 204513-82-6 {4-[5-[(S)-2-Benzyloxycarbonylamino-3-(tert-butyl-dimethyl-silanyloxy)-propyl]-2-(2-cyclohexyl-ethoxy)-phenyl]-butyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Novel biologically active nonpeptidic inhibitors of myristoylcoa:Protein n-myristoyltransferase

A new class of biologically active nonpeptidic inhibitors of Candida albicans NMT has been synthesized starting from the octapeptide ALYASKLS- NH2 (2). The synthetic strategy entailed the preparation of novel protected Ser-Lys mimics 9 and 12 f